[1] |
Yokogoshi H, Kobayashi M.Hypotensive effect of gamma-glutamylmethylamide in spontaneously hypertensive rats[J]. Life Sci, 1998, 62(12): 1065-1068.
|
[2] |
Sugiyama T, Sadzuka Y.Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents[J]. Biochim Biophys Acta, 2003, 1653(2): 47-59.
|
[3] |
Unno K, Fujitani K, Takamori N, et al. Theanine intake improves the shortened lifespan, cognitive dysfunction and behavioural depression that are induced by chronic psychosocial stress in mice[J]. Free Radic Res, 2011, 45(8): 966-974.
|
[4] |
Yin C, Gou L, Liu Y, et al. Antidepressant-like effects of L-theanine in the forced swim and tail suspension tests in mice[J]. Phytother Res, 2011, 25(11): 1636-1639.
|
[5] |
Egashira N, Ishigami N, Pu F, et al. Theanine prevents memory impairment induced by repeated cerebral ischemia in rats[J]. Phytother Res, 2008, 22(1): 65-68.
|
[6] |
Kakuda T.Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction[J]. Pharmacol Res, 2011, 64(2): 162-168.
|
[7] |
Takeda A, Sakamoto K, Tamano H, et al. Facilitated Neurogenesis in the Developing Hippocampus After Intake of Theanine, an Amino Acid in Tea Leaves, and Object Recognition Memory[J]. Cell Mol Neurobiol, 2011, 31(7): 1079-1088.
|
[8] |
Ritsner MS, Miodownik C, Ratner Y, et al. L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study[J]. J Clin Psychiatry, 2011, 72(1): 34-42.
|
[9] |
Cross DR, Kellermann G, McKenzie LB, et al. A randomized targeted amino acid therapy with behaviourally at-risk adopted children[J]. Child: care, health and development, 2011, 37(5): 671-678.
|
[10] |
Yamada T, Nishimura Y, Sakurai T, et al. Administration of theanine, a unique amino acid in tea leaves, changed feeding-relating components in serum and feeding behavior in rats[J]. Biosci Biotechnol Biochem, 2008, 72(5): 1352-1355.
|
[11] |
Zheng G, Sayama K, Okubo T, et al. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice[J]. In Vivo, 2004, 18(1): 55-62.
|
[12] |
Borzelleca JF, Peters D, Hall W.A 13-week dietary toxicity and toxicokinetic study with l-theanine in rats[J]. Food Chem Toxicol, 2006, 44(7): 1158-1166.
|
[13] |
Yamada T, Terashima T, Wada K, et al. Theanine, r-glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation[J]. Life Sci, 2007, 81(16): 1247-1255.
|
[14] |
Yamada T, Terashima T, Honma H, et al. Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test[J]. Biosci Biotechnol Biochem, 2008, 72(5): 1356-1359.
|
[15] |
Nishida K, Yasuda E, Nagasawa K, et al. Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanine-administered rats[J]. Biol Pharm Bull, 2008, 31(5): 857-860.
|
[16] |
Horner KM, Byrne NM, Cleghorn GJ, et al. The effects of weight loss strategies on gastric emptying and appetite control[J]. Obes Rev, 2011, 12(11): 935-951.
|
[17] |
Jiang C, Fogel R, Zhang X.Lateral hypothalamus modulates gut-sensitive neurons in the dorsal vagal complex[J]. Brain Res, 2003, 980(1): 31-47.
|
[18] |
Grabauskas G, Moises HC.Gastrointestinal-projecting neurones in the dorsal motor nucleus of the vagus exhibit direct and viscerotopically organized sensitivity to orexin[J]. J Physiol, 2003, 549(Pt 1): 37-56.
|
[19] |
Kakuda T, Nozawa A, Sugimoto A, et al. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors[J]. Biosci Biotechnol Biochem, 2002, 66(12): 2683-2686.
|
[20] |
Hettes SR, Gonzaga WJ, Heyming TW, et al. Stimulation of lateral hypothalamic AMPA receptors may induce feeding in rats[J]. Brain Res, 2010, 1346: 112-120.
|
[21] |
Fetissov SO, Meguid MM, Sato T, et al. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake[J]. Am J Physiol Regul Integr Comp Physiol, 2002, 283(4): R905-R910.
|
[22] |
Imre G, Fokkema DS, Den Boer JA, et al. Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity[J]. Brain Res Bull, 2006, 69(3): 338-345.
|
[23] |
Jentsch JD, Roth RH.The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia[J]. Neuropsychopharmacology, 1999, 20(3): 201-225.
|